Amylin-based pharmacotherapy - Past, present & future

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2008, Pages 317-324

  Roth, Jonathan D ^a   Mack, Christine M ^a   Soares, Christopher J ^a   Ghosh, Soumitra S ^a   Parkes, David G ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; ANTIOBESITY AGENT; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; HEMOGLOBIN A1C; LEPTIN; METRELEPTIN; OREXIN; PHENTERMINE; PRAMLINTIDE; SIBUTRAMINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEAMINATION; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENERGY EXPENDITURE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IC 50; INJECTION SITE REACTION; INSULIN DEFICIENCY; MONOTHERAPY; NAUSEA; NONHUMAN; OBESITY; RECEPTOR BINDING; SEQUENCE HOMOLOGY; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 70350117820     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152208787169189     Document Type: Article

References (68)

1. Ogawa, A.; Harris, V.; McCorkle, S.K.; Unger, R.H.; Luskey, K.L. J. Clin. Invest., 1990, 85, 973.
2. Young, A.; J. Thomas August, Ferid Murad, Daryl Granner, Eds.; Elsevier Academic Press: San Diego, 2005; 52, 18.
3. Badman, M.K.; Shennan, K.I.; Jermany, J.L.; Docherty, K.; Clark A. FEBS. Lett., 1996, 378, 227.
4. Higham, C.E.; Hull, R.L.; Lawrie, L.; Shennan, K.I.; Morris, J.F.; Birch, N.P.; Docherty, K.; Clark, A. Eur. J. Biochem., 2000, 267, 4998.
5. Silvestre, R.A.; Rodríguez-Gallardo, J.; Jodka, C.; Parkes, D.G.; Pittner, R.A.; Young, A.A.; Marco, J. Am. J. Physiol. Endo. Metab., 2001, 280, E443.
6. Young, A.A.; Gedulin, B.; Vine, W.; Percy, A.; Rink, T.J. Diabetologia, 1995, 38, 642.
7. Lutz, T.A.; Del Prete, E.; Scharrer, E. Physiol. Behav., 1994, 55, 891.
8. Price, C.J.; Hoyda, T.D.; Ferguson, A.V. Neuroscientist, 2008, 14, 182.
9. Hay, D.L.; Christopoulos, G.; Christopoulos, A.; Sexton, P.M. Biochem. Soc. Trans., 2004, 32, 865.
10. Sexton, P.M.; Morfis, M.; Tilakaratne, N.; Hay, D.L.; Udawela, M.; Christopoulos, G.; Christopoulos, A. Ann. N.Y. Acad. Sci., 2006, 1070, 90.
11. Beaumont, K.; Kenney, M.A.; Young, A.A.; Rink T.J. Mol. Pharmacol., 1993, 44, 493.
12. Sexton, P.M.; Paxinos, G.; Kenney, M.A.; Wookey, P.J.; Beaumont, K. Neuroscience, 1994, 62, 553.
13. Oliver, K.R.; Kane, S.A.; Salvatore, C.A.; Mallee, J.J.; Kinsey, A.M.; Koblan, K.S.; Keyvan-Fouladi, N.; Heavens, R.P.; Wainwright, A.; Jacobson, M.; Dickerson, I.M.; Hill, R.G. Eur. J. Neurosci., 2001, 14, 618.
14. Christopoulos, G.; Perry, K.J.; Morfis, M.; Tilakaratne, N.; Gao, Y.; Fraser, N.J.; Main, M.J.; Foord, S.M.; Sexton, PM. Mol. Pharmacol., 1999, 56, 235.
15. Barth, S.W.; Riediger, T.; Lutz, T.A.; Rechkemmer, G. Brain Res., 2004, 997, 97.
16. Rushing, P.A.; Hagan, M.M.; Seeley, R.J.; Lutz, T.A.; Woods, S.C. Endocrinology, 2000, 141, 850.
17. Riediger, T.; Schmid, H.A.; Lutz, T.A.; Simon, E. Neurosci. Lett., 2002, 328, 121.
18. Riediger, T.; Rauch, M,; Schmid, H.A., Am. J. Physiol., 1999, 276, R514.
19. Lutz, T.A.; Senn, M.; Althaus, J.; Del Prete, E.; Ehrensperger, F.; Scharrer, E. Peptides, 1998, 19, 309.
20. Rowland, N.E.; Richmond, R.M. Brain Res., 1999, 820, 86.
21. Riediger, T.; Zuend, D.; Becskei, C.; Lutz, T.A. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004, 286, R114.
22. Lutz, T.A.; Del Prete, E.; Scharrer, E. Peptides, 1995, 16, 457.
23. Jodka, C.; Green, D.; Young, A.; Gedulin, B. Diabetes, 1996, 45(Suppl. 2), 235A.
24. Gedulin, B.R.; Jodka, C.M.; Herrmann, K.; Young, A.A. Regul. Pept., 2006, 137, 121.
25. Phillips, W.T.; Schwartz, J.G.; McMahan, C.A. J. Nucl. Med., 1992, 33, 1496.
26. Schvarcz, E.; Palmér, M.; Aman, J.; Berne C. Acta Diabetol., 1997, 34, 194.
27. Young, A. J. Thomas August, Ferid Murad, Daryl Granner, Eds.; Elsevier Academic Press: San Diego, 2005; Vol. 52, pp. 289-320.
28. Pullman, J.; Darsow, T.; Frias, J.P. Vasc. Health Risk Manag., 2006, 2, 203.
29. Ratner, R.E,; Want, L.L.; Fineman, M.S.; Velte, M.J.; Ruggles, J.A.; Gottlieb, A.; Weyer, C.; Kolterman, O.G. Diabetes Technol. Ther., 2002, 4, 51.
30. Ratner, R.E.; Dickey, R.; Fineman, M.; Maggs, D.G.; Shen, L.; Strobel, S.A.; Weyer, C.; Kolterman, O.G. Diabet. Med., 2004, 21, 1204.
31. Whitehouse, F.; Kruger, D.F.; Fineman, M.; Shen, L.; Ruggles, J.A.; Maggs, D.G.; Weyer, C.; Kolterman, O.G. Diabetes Care, 2002, 25, 724.
32. Hollander, P.; Ratner, R.; Fineman, M.; Strobel, S.; Shen, L.; Maggs, D.; Kolterman, O.; Weyer, C. Diabetes Obes. Metab., 2003, 5, 408.
33. Hollander, P.A.; Levy, P.; Fineman, M.S.; Maggs, D.G.; Shen, L.Z.; Strobel, S.A.; Weyer, C.; Kolterman, O.G. Diabetes Care, 2003, 26, 784.
34. Weyer, C.; Gottlieb, A.; Kim, D.D.; Lutz, K.; Schwartz, S.; Gutierrez, M.; Wang, Y.; Ruggles, J.A.; Kolterman, O.G.; Maggs, D.G. Diabetes Care, 2003, 26, 3074.
35. Maggs, D.G.; Fineman, M.; Kornstein, J.; Burrell, T.; Schwartz, S.; Wang, Y.; Ruggles, J.A.; Kolterman, O.G.; Weyer, C. Diabetes Metab. Res. Rev., 2004, 20, 55.
36. Guthrie, R.; Karl, D.M.; Wang, Y.; Lorenzi, G. Diabetes, 2005, 54(Suppl. 1), A118.
37. Karl, D.; Philis-Tsimikas, A.; Darsow, T.; Lorenzi, G.; Kellmeyer, T.; Lutz, K.; Wang, Y.; Frias, J.P. Diabetes Technol. Ther., 2007, 9, 191.
38. Edelman, S.; Garg, S.; Frias, J.; Maggs, D.; Wang, Y.; Zhang, B.; Strobel, S.; Lutz, K.; Kolterman, O. Diabetes Care, 2006, 29, 2189.
39. Fineman, M.S.; Koda, J.E.; Shen, L.Z.; Strobel, S.A.; Maggs, D.G.; Weyer, C.; Kolterman, O.G. Metabolism, 2002, 51, 636.
40. Samsom, M.; Szarka L.A.; Vella, A.; Daniel, D.A.; Burton, D.; Thomforde, G.M.; Zinsmeister, A.R.; Rizza, R.A.; Camilleri, M. Gastroenterology, 2000, 118, A625.
41. Samsom, M.; Szarka, L.A.; Camilleri, M.; Vella, A.; Zinsmeister, A.R.; Rizza, R.A. Am. J. Physiol. Gastrointest. Liver Physiol., 2000, 278, 946.
42. Kellmeyer, T.A.; Kesty, N.C.; Wang, Y.; Frias, J.P.; Fineman, M.S. J. Clin. Pharmacol., 2007, 47, 789.
43. Kong, M.F.; King, P.; Macdonald, I.A.; Stubbs, T.A.; Perkins, A.C.; Blackshaw, P.E.; Moyses, C.; Tattersall, R.B. Diabetologia, 1997, 40, 82.
44. Vella, A.; Lee, J.S.; Camilleri, M.; Szarka, L.A.; Burton, D.D.; Zinsmeister, A.R.; Rizza, R.A.; Klein, P.D. Neurogastroenterol. Motil., 2002, 14, 123.
45. Edelman, S.V.; Weyer, C. Diabetes Technol. Ther., 2002, 4, 175.
46. Lutz, T.A., Amylinergic control of food intake. Physiol. Behav., 2006. 89, 465.
47. Chen, H.C.; Roth, J.D.; Schroeder, B.E.; Weyer, C. Curr. Diabetes Rev., 2008, 4, 79-91.
48. Roth, J.D.; Mack, C.; Parkes, D.G.; Kesty, N.C.; Weyer, C. In Handbook of Obesity 3rd Edition; George Bray, Claude Bouchard, Eds.; Informa Health Care: New York, 2008; pp. 341-361.
49. Lutz, T.A. Curr. Drug Targets, 2005, 6, 181.
50. Chance, W.T.; Balasubramaniam, A.; Chen, X.; Fischer, J.E. Peptides, 1992, 13, 961.
51. Rushing, P.A.; Seeley, R.J.; Air, E.L.; Lutz, T.A.; Woods, S.C. Peptides, 2002, 23, 985.
52. Mack, C.; Wilson, J.; Athanacio, J.; Reynolds, J.; Laugero, K.; Guss, S.; Vu C.; Roth, J.; Parkes, D. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293, 1855.
53. Laugero, K.D.; Mack, C.; Hanley, M.; Baron, A.; Parkes, D. Society for Neuroscience, 2005, 530, 17.
54. Roth, J.D.; Hughes, H.; Kendall, E.; Baron, A.D,; Anderson, C.M. Endocrinology, 2006, 147, 5855.
55. Roth, J.D.; Hughes, H.; Coffey, T.; Maier, H.; Trevaskis, J.L.; Anderson, C.M. Am. J. Physiol. Endocrinol. Metab., 2007, 293, 1112.
56. Roth, J.D.; Roland, B.L.; Cole, R.L; Trevaskis, J.L.; Weyer, C.; Koda, J.E.; Anderson, C.M.; Parkes, D.G.; Baron, A.D. Proc. Natl. Acad. Sci. USA, 2008, 105, 7257.
57. Barth, S.W.; Riediger, T.; Lutz, T.A.; Rechkemmer, G. Neurosci. Lett., 2003, 341, 131.
58. Hollander, P.; Maggs, D.G.; Ruggles, J.A.; Fineman, M.; Shen, L.; Kolterman, O.G.; Weyer. C. Obes. Res., 2004, 12, 661.
59. Aronne, L.; Fujioka, K., Aroda, V.; Chen, K.; Halseth, A.; Kesty, N.C.; Burns, C.; Lush, CW.; Weyer, C. J. Clin. Endocrinol. Metab., 2007, 92, 2977.
60. Smith, S.R.; Blundell, J.E.; Burns, C.; Ellero, C.; Schroeder, B.E.; Kesty, N.C.; Chen, K.S.; Halseth, A.E.; Lush. C.W.; Weyer, C. Am. J. Physiol. Endocrinol. Metab., 2007, 293, 620.
61. Smith, S.R.; Aronne, L.J.; Burns, C.M.; Kesty, N.C.; Halseth, A.E.; Weyer. C. Diabetes Care, 2008, 31, 1816.
62. Foster, G.D.; Wadden, T.A.; Phelan, S.; Sarwer, D.B.; Sanderson, R.S. Arch. Intern. Med., 2001, 161, 2133.
63. Trevaskis, J.L.; Coffey, T.; Cole, R.; Lei, C.; Wittmer, C.; Walsh, B.; Weyer, C.; Koda, J.; Baron, A.D.; Parkes, D.G.; Roth, J.D. Endocrinology, 2008.
64. Roth, J.D.; Trevaskis, J.L.; Wilson, J.; Lei, C.; Athanacio, J.; Mack, C.; Kesty, N.C.; Coffey, T.; Weyer, C.; Parkes, D.G. Int. J. Obes. (Lond)., 2008, 32, 1201.
65. Aronne, L.; Halseth, A.; Burns, C; Porter, L.; Shen L. Diabetes, 2008. 57(Suppl. 1), 30.
66. Kolterman, O.G. Diabet. Med., 1997, 14, 35.
67. Young, A.A.; Vine, W.; Gedulin, B.R.; Pittner, R.; Janes, S.; Gaeta, L.S.L.; Percy, A.; Moore, C.X.; Koda, J.E.; Rink, T.J.; Beaumont, K. Drug Dev. Res., 1996, 37, 231.
68. Roberts, A.N.; Leighton, B.; Todd, J.A.; Cockburn, D.; Schofield, P.N.; Sutton, R.; Holt, S.; Boyd, Y.; Day, A.J.; Foot, E.A. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 9662.